Sage Therapeutics News - SAGE

Company Name	Stock Ticker Symbol	Market	Type
Sage Therapeutics Inc	SAGE	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.16	1.18%	13.74	12:12:51

Open Price	Low Price	High Price	Close Price	Prev Close
13.87	13.38	13.87		13.58

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	06:30	BW	Sage Therapeutics Announces First Quarter 2024 Financial..
4/17/2024	06:30	BW	Sage Therapeutics Announces Topline Results from Phase 2..
4/11/2024	06:30	BW	Sage Therapeutics to Report First Quarter 2024 Financial..
2/28/2024	06:30	BW	Sage Therapeutics to Present at Upcoming March Investor..
2/21/2024	16:35	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2/15/2024	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:09	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2/14/2024	07:49	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/14/2024	07:20	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/14/2024	06:45	EDGAR2	Form 8-K - Current report
2/14/2024	06:30	BW	Sage Therapeutics Announces Fourth Quarter and Full Year..
1/31/2024	17:25	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
1/31/2024	16:50	EDGAR2	Form 8-K - Current report
1/31/2024	06:30	BW	Sage Therapeutics to Report Fourth Quarter and Full Year..
1/24/2024	16:10	EDGAR2	Form 8-K - Current report
1/23/2024	08:13	EDGAR2	Form SC TO-I - Tender offer statement by Issuer
1/08/2024	06:45	EDGAR2	Form 8-K - Current report
1/08/2024	06:32	BW	Sage Therapeutics to Provide Business Updates at 42nd Annual..
1/08/2024	06:30	BW	Sage Therapeutics Announces Changes to Board of Directors
1/04/2024	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	06:30	BW	Sage Therapeutics to Present at the 42nd Annual J.P. Morgan..
12/19/2023	08:32	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/19/2023	08:30	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/14/2023	06:30	BW	ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
12/08/2023	09:00	EDGAR2	Form SC TO-C - Written communication relating to an issuer..
12/08/2023	08:30	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/08/2023	06:30	BW	Sage Therapeutics to Present at Upcoming November Investor..
11/07/2023	07:39	EDGAR2	Form 8-K - Current report
11/07/2023	07:29	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/07/2023	07:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	06:46	EDGAR2	Form 8-K - Current report
11/07/2023	06:30	BW	Sage Therapeutics Announces Third Quarter 2023 Financial..
10/24/2023	06:30	BW	Sage Therapeutics to Report Third Quarter 2023 Financial..
10/18/2023	07:10	DJN	Sage Therapeutics Gets FDA Orphan Designation for SAGE-718..
10/18/2023	06:30	BW	Sage Therapeutics Announces U.S. Food and Drug..
9/06/2023	06:30	BW	Sage Therapeutics to Present at Upcoming September Investor..
8/31/2023	06:45	EDGAR2	Form 8-K - Current report
8/31/2023	06:30	BW	Sage Therapeutics Implements Strategic Reorganization to..
8/11/2023	08:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	07:51	IHMARKETNEWS	Tuesday’s Wall Street Highlights: Novo Nordisk, RingCentral,..
8/07/2023	08:18	DJN	Sage Therapeutics Shares Slide Premarket After Zurzuvae MDD..
8/07/2023	07:49	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/07/2023	07:26	IHMARKETNEWS	Monday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
8/07/2023	07:23	DJN	Sage Therapeutics Mulls Job, Pipeline Cuts After FDA..
8/07/2023	06:45	EDGAR2	Form 8-K - Current report
8/07/2023	06:30	BW	Sage Therapeutics Announces Second Quarter 2023 Financial..
8/04/2023	22:45	BW	Sage Therapeutics to Host Business Update Webcast and..
8/04/2023	22:42	BW	FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
6/05/2023	06:30	BW	Sage Therapeutics to Present at the Goldman Sachs 44th..